These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 1759514)
1. [The possibility of creating a vaccinal strain of Brucella abortus 19-BA with multiple antibiotic resistance]. Gorelov VN; Gubina EA; Grekova NA; Skavronskaia AG Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):2-4. PubMed ID: 1759514 [TBL] [Abstract][Full Text] [Related]
2. Brucella abortus strain RB51 leucine auxotroph as an environmentally safe vaccine for plasmid maintenance and antigen overexpression. Rajasekaran P; Seleem MN; Contreras A; Purwantini E; Schurig GG; Sriranganathan N; Boyle SM Appl Environ Microbiol; 2008 Nov; 74(22):7051-5. PubMed ID: 18836016 [TBL] [Abstract][Full Text] [Related]
3. DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate. Yang X; Thornburg T; Walters N; Pascual DW Vaccine; 2010 Jan; 28(4):1069-74. PubMed ID: 19914192 [TBL] [Abstract][Full Text] [Related]
4. Identification of Brucella abortus B19 vaccine strain by the detection of DNA polymorphism at the ery locus. Sangari FJ; Agüero J Vaccine; 1994 Apr; 12(5):435-8. PubMed ID: 7912870 [TBL] [Abstract][Full Text] [Related]
5. Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice. Tibor A; Jacques I; Guilloteau L; Verger JM; Grayon M; Wansard V; Letesson JJ Infect Immun; 1998 Nov; 66(11):5561-4. PubMed ID: 9784574 [TBL] [Abstract][Full Text] [Related]
6. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs]. Bolpe J; de Lapenta DF; García-Carrillo C Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of the immunobiological properties of live brucellosis vaccines. Salmakov KM; Fomin AM; Plotnikova EM; Safina GM; Galimova GM; Salmakova AV; Ivanov AV; Panin AN; Sklyarov OD; Shumilov KV; Klimanov AI Vaccine; 2010 Oct; 28 Suppl 5():F35-40. PubMed ID: 20362201 [TBL] [Abstract][Full Text] [Related]
8. Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus. Truong QL; Cho Y; Park S; Kim K; Hahn TW Vaccine; 2016 Jan; 34(2):237-244. PubMed ID: 26616550 [TBL] [Abstract][Full Text] [Related]
9. Comparative genomic analysis of Brucella abortus vaccine strain 104M reveals a set of candidate genes associated with its virulence attenuation. Yu D; Hui Y; Zai X; Xu J; Liang L; Wang B; Yue J; Li S Virulence; 2015; 6(8):745-54. PubMed ID: 26039674 [TBL] [Abstract][Full Text] [Related]
10. Resistance of normal or immunized guinea pigs against a subcutaneous challenge of Brucella abortus. Pardon P; Marly J Ann Rech Vet; 1978; 9(3):419-25. PubMed ID: 107845 [TBL] [Abstract][Full Text] [Related]
11. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge. Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799 [TBL] [Abstract][Full Text] [Related]
12. Immunization of guinea pigs with Salmonella delivered anti-Brucella formulation reduces organs bacterial load and mitigates histopathological consequences of Brucella abortus 544 challenge. Lalsiamthara J; Lee JH Vet Immunol Immunopathol; 2018 Jan; 195():40-45. PubMed ID: 29249316 [TBL] [Abstract][Full Text] [Related]
13. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice. Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887 [TBL] [Abstract][Full Text] [Related]
14. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice. Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798 [TBL] [Abstract][Full Text] [Related]
15. Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice. de Souza Filho JA; de Paulo Martins V; Campos PC; Alves-Silva J; Santos NV; de Oliveira FS; Menezes GB; Azevedo V; Cravero SL; Oliveira SC Infect Immun; 2015 Apr; 83(4):1458-64. PubMed ID: 25644010 [TBL] [Abstract][Full Text] [Related]
16. Identification of novel drug targets for humans and potential vaccine targets for cattle by subtractive genomic analysis of Brucella abortus strain 2308. Mahmud A; Khan MT; Iqbal A Microb Pathog; 2019 Dec; 137():103731. PubMed ID: 31509762 [TBL] [Abstract][Full Text] [Related]
18. Immunization with recombinant GntR plasmid confers protection against Brucella challenge in BALB/c mice. Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Han J; Zhang J Microb Pathog; 2017 Oct; 111():357-361. PubMed ID: 28916314 [TBL] [Abstract][Full Text] [Related]
19. The immune response of guinea pigs and buffalo calves to the locally prepared Brucella abortus strain 19 vaccine. Jamal SM; Afzal M; Ahmed S Rev Sci Tech; 2003 Dec; 22(3):893-7. PubMed ID: 15005547 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of Brucella abortus vaccine strain A19 reveals its potential mechanism of attenuated virulence. Cheng Z; Li Z; Yin Y; Lian Z; Abdelgawad HA; Hu H; Guan X; Zuo D; Cai Y; Ding C; Wang S; Li T; Qi J; Tian M; Yu S Vet Microbiol; 2021 Mar; 254():109007. PubMed ID: 33582483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]